Hematology NewsCLARITY: Ibrutinib/venetoclax combo results look promising for relapsed/refractory CLLDecember 10, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsUpdated ZUMA-1 data show durable CAR-T responses in B-cell lymphomasDecember 10, 2017Aggressive LymphomasCellular TherapyIndolent LymphomaLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncologyFollicular Lymphoma
Hematology NewsGuideline preview: ASH to recommend against VTE prophylaxis for lower-risk cancer patientsDecember 10, 2017Thrombosis
Hematology NewsAvapritinib yields high response rate in patients with systemic mastocytosisDecember 10, 2017Myelodysplastic SyndromeMantle Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsIntrabone gene therapy shows promise in beta-thalassemiaDecember 10, 2017Bleeding Disorders
Hematology NewsGene therapy normalized or near-normalized factor VIII in hemophilia ADecember 10, 2017Bleeding Disorders
Hematology NewsGene therapy regimen for XSCID shows rapid results in newly diagnosed infantsDecember 9, 2017Cellular Therapy
Hematology NewsHAVEN 2: Emicizumab represents new standard of care for hemophilia A with inhibitorsDecember 9, 2017Bleeding Disorders
Hematology NewsPolymerization inhibitor improves hemoglobin levels in adolescents with SCDDecember 9, 2017Bleeding Disorders
Hematology NewsSickle cell: Customized stem cells may improve transfusion efficacy, safetyDecember 9, 2017Bleeding Disorders
Oncology PracticeVIDEO: Novel PARP inhibitor boosts PFS in HER2– breast cancer with BRCA mutationsDecember 9, 2017Breast Cancer
Oncology PracticeDNA vaccine + PD-1 blockade shows promise in mCRPCDecember 9, 2017Immuno-oncologyImmunotherapyGenitourinary Cancer
Oncology PracticeOvarian suppression during breast cancer chemo helps stave off early menopause, preserve fertilityDecember 9, 2017Breast CancerPatient & Survivor Care
Oncology PracticeVIDEO: Weight loss cut risk of breast cancerDecember 8, 2017Breast CancerPatient & Survivor Care
Oncology PracticeAdjuvant trastuzumab for 1 year remains standard of care for early HER2+ breast cancerDecember 8, 2017Breast Cancer